Page 52 - Mastología 2 2017 web

cy during pregnancy and risk of neuro- 71. C
developmental disorders in offspring: a
systematic review and meta-analysis. Clin
Endocrinol (Oxf).2018;88(4):575–584.
65. Glinoer D, Riahi M, Grün JP, Kinthaert
J. Risk of subclinical hypothyroidism in
pregnant women with asymptomatic 72.
autoimmune thyroid disorders. J Clin
Endocrinol Metab.1994;79(1):197–204.
66. Y oshioka W, Amino N, Ide A, Kang S,
Kudo T, Nishihara E, Ito M, Nakamu-
ra H, Miyauchi A. Thyroxine treatment
may be useful for subclinical hypothy-
roidism in patients with female infertili- 73.
ty. Endocr J. 2015;62(1):87–92.
67. Abdel Rahman AH, Aly Abbassy H, Ab-
bassy AA. Improved in vitro fertilization
outcomes after treatment of subclinical
hypothyroidism in infertile women. En-
docr Pract.2010;16(5):792–797.
74.
68. Kim CH, Ahn JW, Kang SP, Kim SH,
Chae HD, Kang BM. Effect of levothy-
roxine treatment on in vitro fertiliza-
tion and pregnancy outcome in infertile
women with subclinical hypothyroid-
ism undergoing in vitro fertilization/
intracytoplasmic sperm injection. Fertil
Steril.2011;95(5):1650–1654.
69. W ang H, Gao H, Chi H, Zeng L, Xiao W,
Wang Y, Li R, Liu P, Wang C, Tian Q,
Zhou Z, Yang J, Liu Y, Wei R, Mol BWJ,
Hong T, Qiao J. Effect of levothyroxine on
miscarriage among women with normal
thyroid function and thyroid autoimmu-
nity undergoing in vitro fertilization and
embryo transfer: a randomized clinical
trial. JAMA. 2017;318(22):2190–2198.
70. Cai Y, Zhong L, Guan J, Guo R, Niu B,
Ma Y, Su H. Outcome of in vitro fer-
tilization in women with subclinical
hypothyroidism. Reprod Biol Endocri-
nol. 2017;15(1):39.
48
ommittee on Patient Safety and Qual-
ity Improvement Committee on Pro-
fessional Liability. ACOG Committee
opinion no. 381: subclinical hypothy-
roidism in pregnancy. Obstet Gyne-
col. 2007;110(4):959–960.
F ang Y, Yao L, Sun J, Zhang J, Li Y, Yang
R, Yang K, Tian L. Appraisal of clinical
practice guidelines on the management
of hypothyroidism in pregnancy using
the Appraisal of Guidelines for Research
and Evaluation II instrument. Endo-
crine. 2018;60(1):4–14.
N egro R, Schwartz A, Gismondi R, Tinel-
li A, Mangieri T, Stagnaro-Green A. Uni-
versal screening versus case finding for
detection and treatment of thyroid hor-
monal dysfunction during pregnancy. J
Clin Endocrinol Metab. 2010;95(4):1699–
1707.
H ales C, Taylor PN, Channon S, Paradice
R, McEwan K, Zhang L, Gyedu M,
Bakhsh A, Okosieme O, Muller I, Dra-
man MS, Gregory JW, Dayan C, Lazarus
JH, Rees DA, Ludgate M. Controlled
antenatal thyroid screening II: effect of
treating maternal sub-optimal thyroid
function on child cognition. J Clin Endo-
crinol Metab. 2018;103(4):1583–1591.
75. Maraka S, Singh Ospina NM, O’Keeffe
DT, Rodriguez-Gutierrez R, Espinosa De
Ycaza AE, Wi CI, Juhn YJ, Coddington
CC III, Montori VM, Stan MN. Effects of
levothyroxine therapy on pregnancy out-
comes in women with subclinical hypo-
thyroidism. Thyroid. 2016;26(7):980–986.
76. Ma L, Qi H, Chai X, Jiang F, Mao S, Liu J,
Zhang S, Lian X, Sun X, Wang D, Ren J,
Yan Q. The effects of screening and inter-
vention of subclinical hypothyroidism
on pregnancy outcomes: a prospective
multicenter single-blind, randomized,
S.O.G.B.A.